Inactive Instrument

China Pharma Holdings, Inc. Stock OTC Bulletin Board

US16941T1043

Chart China Pharma Holdings, Inc.

Duration

Period

Style

Dynamic Chart

Latest news about China Pharma Holdings, Inc.

China Pharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
China Pharma to Conduct 1-For-5 Reverse Stock Split; Shares Fall After-Hours	Feb. 23	MT
China Pharma Holdings, Inc. Announces the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device	Nov. 29	CI
North China Pharmaceutical Gets Nod to Market Ampicillin API	Nov. 20	MT
China Pharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
China Pharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
North China Pharma Unit Passes Compliance Inspection	23-03-31	MT
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
China Pharma Holdings, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29	CI
China Pharma Holdings, Inc. Announces Launch of N95 Medical Protective Mask	22-12-28	CI
Top Midday Gainers	22-12-05	MT
China Pharma Holdings Acquires Patented Dry Eye Disease Therapeutic Device Project; Shares Jump	22-12-05	MT
China Pharma Holdings, Inc. Announces Acquisition of Dry Eye Disease Therapeutic Device Project	22-12-05	CI

More news

Press releases China Pharma Holdings, Inc.

CHINA PHARMA HOLDINGS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-04-20	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-03-30	AQ
China Pharma : Current Report - Form 8-K	23-03-29	PU
CHINA PHARMA HOLDINGS, INC. : Other Events (form 8-K)	23-03-29	AQ
CHINA PHARMA HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-02-24	AQ

More press releases

Managers and Directors - China Pharma Holdings, Inc.

Managers	Title	Age	Since
Zhi Lin Li CEO	Chief Executive Officer	71	99-01-27

Members of the board	Title	Age	Since
Zhi Lin Li CEO	Chief Executive Officer	71	99-01-27
Gene Bennett BRD	Director/Board Member	76	08-01-31
Heung Mei Tsui BRD	Director/Board Member	67	09-04-27

More insiders

China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.

Sector

Pharmaceuticals

Calendar

2025-05-14 - Q1 2025 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B
PFIZER, INC.	+0.45%	164B

Other Pharmaceuticals

Sales 2022	8.1M	Sales 2023	7.01M	Capitalization	3.99M
Net income 2022	-3M	Net income 2023	-3M	EV / Sales 2022	1.44 x
Net Debt 2022	6.73M	Net Debt 2023	3.21M	EV / Sales 2023	1.03 x
P/E ratio 2022	-1.27 x	P/E ratio 2023	-0.66 x	Employees	-
Yield 2022 *	-	Yield 2023	-	Free-Float	37.79%